Search Results - "Pacini, F."

Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up by Pacini, F, Castagna, M G, Brilli, L, Pentheroudakis, G

Get full text

Observation for newly diagnosed micro-papillary thyroid cancer: is now the time? by Pacini, F.

Get full text

Italian consensus on diagnosis and treatment of differentiated thyroid cancer: joint statements of six Italian societies by Pacini, F., Basolo, F., Bellantone, R., Boni, G., Cannizzaro, M. A., De Palma, M., Durante, C., Elisei, R., Fadda, G., Frasoldati, A., Fugazzola, L., Guglielmi, R., Lombardi, C. P., Miccoli, P., Papini, E., Pellegriti, G., Pezzullo, L., Pontecorvi, A., Salvatori, M., Seregni, E., Vitti, P.

“…Background Thyroid nodules are a common clinical problem, and differentiated thyroid cancer is becoming increasingly prevalent. Methods Six scientific Italian…”
Get full text

Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up by Pacini, F., Castagna, M. G., Brilli, L., Pentheroudakis, G.

Get full text

Publish or perish? Perish to publish? (Unrequested advices to young researchers) by Ambrosino, N., Pacini, F.

Get full text

Baseline serum TSH levels predict the absence of thyroid dysfunction in cancer patients treated with immunotherapy by Brilli, L., Danielli, R., Campanile, M., Secchi, C., Ciuoli, C., Calabrò, L., Pilli, T., Cartocci, A., Pacini, F., Di Giacomo, A. M., Castagna, M. G.

“…Purpose Immunotherapy against immune checkpoints has significantly improved survival both in metastatic and adjuvant setting in several types of cancers…”
Get full text

Medullary Thyroid Carcinoma by Pacini, F, Castagna, M.G, Cipri, C, Schlumberger, M

“…Abstract Medullary thyroid carcinoma (MTC) accounts for 5–8% of all thyroid cancers. MTC is mainly sporadic in nature, but an hereditary pattern [multiple…”
Get full text

Reappraisal of the indication for radioiodine thyroid ablation in differentiated thyroid cancer patients by Castagna, M. G., Cantara, S., Pacini, F.

“…Radioactive iodine therapy is administered to patients with differentiated thyroid cancer (DTC) for eradication of thyroid remnant after total thyroidectomy…”
Get full text

MicroRNA expression profile of thyroid nodules in fine-needle aspiration cytology: a confirmatory series by Castagna, M. G., Marzocchi, C., Pilli, T., Forleo, R., Pacini, F., Cantara, S.

“…Introduction MiRNAs are small endogenous non-coding RNAs implicated with gene expression regulation. Changes in miRNA levels have been reported in thyroid…”
Get full text

Variants in MCT10 protein do not affect FT3 levels in athyreotic patients by Cantara, S., Ricci, C., Maino, F., Marzocchi, C., Pacini, F., Castagna, M. G.

“…Purpose Several single-nucleotide polymorphisms in genes encoding for transporters have been associated with serum thyroid hormone concentrations with…”
Get full text

Recommendations for post-surgical thyroid ablation in differentiated thyroid cancer: a 2015 position statement of the Italian Society of Endocrinology by Pacini, F., Brianzoni, E., Durante, C., Elisei, R., Ferdeghini, M., Fugazzola, L., Mariotti, S., Pellegriti, G.

“…Post-surgical ablation of thyroid remnant with radioactive iodine (RAI) in differentiated thyroid cancer (DTC) is aimed to destroy any thyroid remnant in the…”
Get full text

HABP2 G534E variation in familial non-medullary thyroid cancer: an Italian series by Cantara, S., Marzocchi, C., Castagna, M. G., Pacini, F.

“…Introduction Thyroid cancer may have a familial predisposition and may occur in the context of hereditary syndromes or as isolated tumor. Recently, the G534E…”
Get full text

Recommendations for treatment of hypothyroidism with levothyroxine and levotriiodothyronine: a 2016 position statement of the Italian Society of Endocrinology and the Italian Thyroid Association by Biondi, B., Bartalena, L., Chiovato, L., Lenzi, A., Mariotti, S., Pacini, F., Pontecorvi, A., Vitti, P., Trimarchi, F.

“…Levothyroxine (L-T4) is recommended as lifelong replacement therapy for hypothyroidism. Recent clinical and experimental data support the addition of…”
Get full text

Intranasal trans-sialidase-based vaccine against Trypanosoma cruzi triggers a mixed cytokine profile in the nasopharynx-associated lymphoid tissue and confers local and systemic immunogenicity by Pacini, María F., Balbi, Camila Bulfoni, Dinatale, Brenda, González, Florencia B., Prochetto, Estefania, De Hernández, María A., Cribb, Pamela, Farré, Cecilia, Espariz, Martín, Blancato, Víctor S., Magni, Christian, Marcipar, Iván, Pérez, Ana R.

“…Trypanosoma cruzi, the agent of Chagas disease, can infect through conjunctive or oral mucosas. Therefore, the induction of mucosal immunity by vaccination is…”
Get full text

Immune response triggered by Trypanosoma cruzi infection strikes adipose tissue homeostasis altering lipid storage, enzyme profile and adipokine expression by González, Florencia B., Villar, Silvina R., Toneatto, Judith, Pacini, María F., Márquez, Julia, D’Attilio, Luciano, Bottasso, Oscar A., Piwien-Pilipuk, Graciela, Pérez, Ana R.

“…Adipose tissue is a target of Trypanosoma cruzi infection being a parasite reservoir during the chronic phase in mice and humans. Previously, we reported that…”
Get full text

Chronic lymphocytic thyroiditis (CLT) has a positive prognostic value in papillary thyroid cancer (PTC) patients: the potential key role of Foxp3+ T lymphocytes by Pilli, T., Toti, P., Occhini, R., Castagna, M. G., Cantara, S., Caselli, M., Cardinale, S., Barbagli, L., Pacini, F.

“…Background An impact of chronic lymphocytic thyroiditis (CLT) on papillary thyroid cancer (PTC) outcome has long been advocated but it is still controversial…”
Get full text

Small papillary thyroid carcinoma with minimal extrathyroidal extension should be managed as ATA low-risk tumor by Castagna, M. G., Forleo, R., Maino, F., Fralassi, N., Barbato, F., Palmitesta, P., Pilli, T., Capezzone, M., Brilli, L., Ciuoli, C., Cantara, S., Formichi, C., Pacini, F.

“…Purpose According to American Thyroid Association (ATA) guideline, papillary thyroid cancer (PTC) with minimal extrathyroidal extension (mETE) is classified at…”
Get full text

Features and outcome of differentiated thyroid carcinoma associated with Graves’ disease: results of a large, retrospective, multicenter study by Premoli, P., Tanda, M. L., Piantanida, E., Veronesi, G., Gallo, D., Masiello, E., Rosetti, S., Cusini, C., Boi, F., Bulla, J., Rodia, R., Mariotti, S., Capelli, V., Rotondi, M., Magri, F., Chiovato, L., Rocchi, R., Campopiano, M. C., Elisei, R., Vitti, P., Barbato, F., Pilli, T., Castagna, M. G., Pacini, F., Bartalena, L.

“…Background Whether differentiated thyroid cancer (DTC) occurring concomitantly with Graves’ disease (GD) is more aggressive and bound to a less favorable…”
Get full text

BROX haploinsufficiency in familial nonmedullary thyroid cancer by Pasquali, D., Torella, A., Accardo, G., Esposito, D., Del Vecchio Blanco, F., Salvatore, D., Sabatino, P., Pacini, F., Barbato, F., Castagna, M. G., Cantara, S., Nigro, V.

“…Background The familial nonmedullary thyroid cancer (FNMTC) is suspected to be a Mendelian condition in up to 3–8% of thyroid cancers. The susceptibility…”
Get full text

Radioiodine Ablation of Thyroid Remnants after Preparation with Recombinant Human Thyrotropin in Differentiated Thyroid Carcinoma: Results of an International, Randomized, Controlled Study by Pacini, F., Ladenson, P. W., Schlumberger, M., Driedger, A., Luster, M., Kloos, R. T., Sherman, S., Haugen, B., Corone, C., Molinaro, E., Elisei, R., Ceccarelli, C., Pinchera, A., Wahl, R. L., Leboulleux, S., Ricard, M., Yoo, J., Busaidy, N. L., Delpassand, E., Hanscheid, H., Felbinger, R., Lassmann, M., Reiners, C.

“…Context: After surgery for differentiated thyroid carcinoma, many patients are treated with radioiodine to ablate remnant thyroid tissue. This procedure has…”
Get full text